venBio Partners’s Alumis Inc ALMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Hold
4,528,408
24.53% 3
2026
Q1
$99.8M Sell
4,528,408
-91,395
-2% -$2.28M 35.56% 2
2025
Q4
$45.1M Hold
4,619,803
20.85% 2
2025
Q3
$18.4M Hold
4,619,803
10.45% 2
2025
Q2
$13.9M Buy
4,619,803
+1,832,405
+66% +$8.65M 12.08% 3
2025
Q1
$17.1M Hold
2,787,398
13.85% 2
2024
Q4
$21.9M Sell
2,787,398
-38,650
-1% -$387K 12.83% 2
2024
Q3
$30.2M Hold
2,826,048
15.53% 2
2024
Q2
$37.6M Buy
+2,826,048
New +$37.6M 16.23% 3

Other funds holding ALMS

venBio Partners's ALMS Position: Q2 2026 in Review

venBio Partners held its Alumis Inc (ALMS) position steady in Q2 2026 at 4,528,408 shares worth $127M. The position accounts for 24.53% of the portfolio, ranked #3.

venBio Partners first reported a position in ALMS in Q2 2024 and has held it in 9 quarters since. 198 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

  • venBio Partners held 4,528,408 shares of Alumis Inc worth $127M as of Q2 2026.
  • venBio Partners left its Alumis Inc share count unchanged in Q2 2026.
  • Alumis Inc made up 24.53% of venBio Partners's portfolio in Q2 2026, its #3 holding.
  • venBio Partners first reported a position in Alumis Inc in Q2 2024 and has held it in 9 quarters since.
  • 198 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on venBio Partners's 13F filing for Q2 2026, filed 14 Aug 2026.